- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 209/16 - Tryptamines
Patent holdings for IPC class C07D 209/16
Total number of patents in this class: 679
10-year publication summary
|
17
|
6
|
11
|
17
|
56
|
95
|
147
|
106
|
111
|
33
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Caamtech, Inc. | 152 |
83 |
| Compass Pathfinder Limited | 119 |
37 |
| Mindset Pharma Inc. | 66 |
36 |
| Enveric Biosciences Canada Inc. | 65 |
35 |
| Cybin IRL Limited | 69 |
19 |
| Beckley Psytech Limited | 45 |
19 |
| Atai Therapeutics, Inc. | 89 |
18 |
| Cybin UK Ltd | 43 |
18 |
| Terran Biosciences, Inc. | 107 |
16 |
| Gilgamesh Pharmaceuticals, Inc. | 61 |
15 |
| Psilo Scientific Ltd. | 54 |
14 |
| Psilera Inc. | 13 |
9 |
| Zylorion Health Inc. | 14 |
9 |
| MagicMed Industries Inc. | 9 |
8 |
| GH Research Ireland Limited | 89 |
8 |
| Reunion Neuroscience Inc. | 18 |
8 |
| H. Lundbeck A/S | 1232 |
7 |
| Small Pharma Limited | 16 |
7 |
| Eleusis Therapeutics US, Inc. | 25 |
6 |
| Canna Chemistries LLC | 11 |
6 |
| Other owners | 301 |